Skip to content

Clinical trials

Terminated Phase 2 Glomerulonephritis, IGA trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 2 Status: Terminated Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20192
20212
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
Alnylam Pharmaceuticals1
Aravive, Inc.1
BioCryst Pharmaceuticals1
EMD Serono Research & Development Institute, Inc.1
Eledon Pharmaceuticals1
Guangdong Hengrui Pharmaceutical Co., Ltd1
Omeros Corporation1
RemeGen Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA10
Lupus Nephritis3
Proteinuria3
Glomerulonephritis2
Glomerulonephritis, Membranous2
Glomerulonephritis, Membranoproliferative1
Kidney Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.